Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis - PubMed (original) (raw)
Comparative Study
Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis
C Bologna et al. Br J Rheumatol. 1996 May.
Abstract
The objective of this study was to assess the influence of age on the efficacy and toxicity of methotrexate in rheumatoid arthritis. Four hundred and sixty-nine patients were separated according to the age of onset of methotrexate treatment: before 65 yr (group 1, n = 416) and after 65 yr (group 2, n = 53). No difference was found in the evolution of clinical and biological parameters between the two groups. The number of patients in remission at the end of the study was equal. The frequency and type of side-effects were similar. No significant difference was found in the frequency and reasons for methotrexate withdrawal. We noted a trend towards lower therapeutic maintenance of methotrexate when prescribed after the age of 65 yr (P = 0.07, actuarial method). In conclusion, the age at initiation of methotrexate treatment probably did not influence its efficacy and toxicity in rheumatoid arthritis.
Similar articles
- Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG. Bijlsma JWJ, et al. Lancet. 2016 Jul 23;388(10042):343-355. doi: 10.1016/S0140-6736(16)30363-4. Epub 2016 Jun 7. Lancet. 2016. PMID: 27287832 Clinical Trial. - Efficacy of methotrexate in rheumatoid arthritis.
Ali ML, Alam MN, Haq SA, Das KK, Baral PK. Ali ML, et al. Bangladesh Med Res Counc Bull. 1997 Dec;23(3):72-6. Bangladesh Med Res Counc Bull. 1997. PMID: 9621475 Clinical Trial. - Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open, retrospective, observational study.
Bologna C, Viu P, Picot MC, Jorgensen C, Sany J. Bologna C, et al. Br J Rheumatol. 1997 May;36(5):535-40. doi: 10.1093/rheumatology/36.5.535. Br J Rheumatol. 1997. PMID: 9189054 - Methotrexate use in rheumatoid arthritis.
O'Dell JR. O'Dell JR. Rheum Dis Clin North Am. 1997 Nov;23(4):779-96. doi: 10.1016/s0889-857x(05)70360-4. Rheum Dis Clin North Am. 1997. PMID: 9361155 Review. - Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?
Ranganathan P, Eisen S, Yokoyama WM, McLeod HL. Ranganathan P, et al. Ann Rheum Dis. 2003 Jan;62(1):4-9. doi: 10.1136/ard.62.1.4. Ann Rheum Dis. 2003. PMID: 12480661 Free PMC article. Review.
Cited by
- Rheumatoid arthritis in the elderly in the era of tight control.
Soubrier M, Tatar Z, Couderc M, Mathieu S, Dubost JJ. Soubrier M, et al. Drugs Aging. 2013 Nov;30(11):863-9. doi: 10.1007/s40266-013-0122-8. Drugs Aging. 2013. PMID: 24105334 Review. - Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.
Hoekstra M, van Ede AE, Haagsma CJ, van de Laar MA, Huizinga TW, Kruijsen MW, Laan RF. Hoekstra M, et al. Ann Rheum Dis. 2003 May;62(5):423-6. doi: 10.1136/ard.62.5.423. Ann Rheum Dis. 2003. PMID: 12695153 Free PMC article. Clinical Trial. - Optimising low-dose methotrexate for rheumatoid arthritis-A review.
Lucas CJ, Dimmitt SB, Martin JH. Lucas CJ, et al. Br J Clin Pharmacol. 2019 Oct;85(10):2228-2234. doi: 10.1111/bcp.14057. Epub 2019 Aug 9. Br J Clin Pharmacol. 2019. PMID: 31276602 Free PMC article. Review. - Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?
Romão VC, Lima A, Bernardes M, Canhão H, Fonseca JE. Romão VC, et al. Immunol Res. 2014 Dec;60(2-3):289-310. doi: 10.1007/s12026-014-8564-6. Immunol Res. 2014. PMID: 25391609 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical